Ruibo (Hangzhou) Pharmaceutical Technology Co., Ltd. announced a private placement of common shares for gross proceeds of CNY 20,000,000 on September 4, 2023. The transaction will include participation from returning investor Zhejiang Jiuzhou Pharmaceutical Co., Ltd. Upon completion, the registered capital of the company will increase from CNY 89,051,094.89 to CNY 91,970,802.92. The transaction has been approved in the 36th meeting of the seventh board of directors and the 26th meeting of the seventh board of supervisors board.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
15.6 CNY | +3.24% | +5.62% | -35.56% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-35.56% | 1.94B | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- 603456 Stock
- News Zhejiang Jiuzhou Pharmaceutical Co., Ltd
- Ruibo Pharmaceutical Technology Co., Ltd. announced that it expects to receive CNY 20 million in funding from Zhejiang Jiuzhou Pharmaceutical Co., Ltd